Neal Fedarko, Johns Hopkins Univ.
This theme is made up of four symposia, one scheduled each
day of the meeting, Sun – Wed. Please
read below for invited speaker and session schedule information. In addition to the invited talks listed
below, short talks will be selected from the submitted abstracts. To be considered for a volunteered talk in
this theme, submit your abstract to an ASBMB topic category number: 2330-2348,
by the November 8th submission deadline. All volunteered abstracts will be programmed
for poster presentation. Those selected
for oral presentation will also present a poster. Programming notifications will be sent in mid-January. We look forward to seeing you at the Boston
Convention and Exhibition Center, BCEC, March 28 – April 1, 2015.
Imaging: A Picture is Worth > 1,000 Words
Sunday, March 29, 2015, Session time, tba
Session Chair: Neal Fedarko, Johns Hopkins Univ.
Carolyn J. Anderson,
Univ. of Pittsburgh
Novel molecular imaging agents as therapeutics
Jason S. Lewis, Memorial Sloan Kettering Cancer Ctr.
PET radiopharmaceuticals for the diagnosis of cancer
Elizabeth A. Maher, UT Southwestern Med. Ctr.
Metabolic Imaging of IDH mutant gliomas
RNA: Beyond Messages and Translation (Micro and Long
Monday, March 30, 2015, Session time, tba
Session Chair: Carlo M. Croce, The Ohio State Univ.
Carlo M. Croce, The Ohio State Univ.
miRNA and long noncoding RNAs in cancer
Muller Fabbri, Univ. of Southern California
Role of exosomic microRNAs in cancer cell cross-talk within the tumor
Cheryl D. Helgason, Univ. of British Columbia
The non-coding transcriptome as a dynamic regulator of cancer metastasis
Metabolism: Warburg at 90
Tuesday, March 31, 2015, Session time, tba
Session Chair: Elizabeth A. Maher, UT Southwestern Med. Ctr.
Jules L. Griffin, Univ. of Cambridge, UK
Using comparative metabolomics to target breast cancers
Craig B. Thompson, Memorial Sloan Kettering Cancer Ctr.
Therapeutic targets in cancer cell metabolism
David L. Wishart, Univ. of Alberta
Biologics: Antibodies and Antidotes
Wednesday, April 1, 2015, Session time, tba
Session Chair: Muller Fabri, Univ. of Southern California
Lieping Chen, Yale Univ. Sch. Of Med.
Tumor site Immune modulation therapy
Nicholas P. Restifo, NCI, NIH
Adoptive cell therapy
Martine J. Smit, VU Univ., Amsterdam
GPCR-targeting nanobodies as attractive research tools, diagnostics and